(MedPage Today) — The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first treatment for acute hepatitis C virus, AbbVie announced.
Compared with no treatment for chronic hepatitis…
Source link : https://www.medpagetoday.com/gastroenterology/generalgastroenterology/116048
Author :
Publish date : 2025-06-12 19:38:00
Copyright for syndicated content belongs to the linked Source.
